Metabolic Biomarkers in Heart Failure
Chonyang L Albert1, W H Wilson Tang2
1Department of Cardiovascular Medicine, Heart & Vascular Institute, Cleveland Clinic, Cleveland, OH 44106, USA.
Heart Failure Clinics
|November 21, 2017
Summary
Metabolomics, the study of metabolites, uses advanced technology to analyze heart failure and environmental links. This field offers new biomarkers and therapies for cardiovascular disease.
Area of Science:
- Biochemistry and Molecular Biology
- Environmental Health Sciences
Background:
- Metabolomics involves the study of small organic molecules in biochemical pathways.
- Technological advancements in nuclear magnetic resonance, gas chromatography, and mass spectrometry enable large-scale metabolite analysis.
Purpose of the Study:
- To explore the role of metabolomics in understanding heart failure.
- To investigate the connection between environmental exposures and cardiovascular disease development.
Main Methods:
- Utilizing advanced analytical techniques such as nuclear magnetic resonance (NMR), gas chromatography (GC), and mass spectrometry (MS).
- Analyzing large databases of metabolites associated with heart failure.
- Examining patient and environmental interactions.
Main Results:
- Identification of numerous metabolites implicated in heart failure.
- Unlocking potential links between environmental factors and cardiovascular disease.
Conclusions:
- Metabolomics is a rapidly advancing field with significant clinical potential for heart failure.
- The field is expected to yield novel biomarkers and therapeutic strategies for cardiovascular conditions.
Keywords:
AcylcarnitineArginineHeart failure metabolomicsMyocardial energy utilizationNitric oxideTMAOMore Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.9K
11:26Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
9.2K
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
622
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
622
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
942
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
942
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
01:17Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
01:26Heart Failure III: Clinical Manifestations
658
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
658
01:27Heart Failure I: Introduction
987
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
987